Mode
Text Size
Log in / Sign up
N/A N=134 Randomized Single-blind Health Services Research

PTSD (PostTraumatic Stress Disorder) Services for Veterans With SMI (Severe Mental Illness)

Post Traumatic Stress Disorder · Schizophrenia · Schizoaffective Disorder · Bipolar Disorder · Major Depression

Enrolled (actual)
134
Serious AEs
0.8%
Results posted
Jul 2019
Primary outcome: Primary: Posttraumatic Stress Disorder (PTSD) Checklist (PCL) — 66.94; 66.33; 51.20; 60.60 score on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Prolonged Exposure for PTSD (PE) + Treatment as Usual (TAU) (Behavioral); Treatment As Usual (TAU) (Behavioral)
Age
Adult, Older Adult · 21+ yrs
Sex
All
Sponsor
VA Office of Research and Development
Primary completion
Dec 2016

Outcome Measures

OutcomeResultp-value
PRIMARY
Posttraumatic Stress Disorder (PTSD) Checklist (PCL)
66.94; 66.33; 51.20; 60.60
PRIMARY
Clinician Administered Posttraumatic Stress Disorder Scale (CAPS)
69.00; 62.91; 49.42; 68.42
SECONDARY
Beck Depression Inventory-II (BDI-II)
37.26; 31.54; 26.52; 30.00
SECONDARY
Brief Psychiatric Rating Scale-Extended (BPRS-E)
47.34; 44.87; 33.72; 35.29
SECONDARY
Veterans SF 12 Health Survey (SF-12)
36.69; 42.48; 44.31; 42.70
SECONDARY
Pittsburgh Seep Quality Index
2.47; 2.45; 2.00; 2.29

Summary

As in the general population, there is no clear standard of care within Veterans Affairs Medical Centers for treating posttraumatic stress disorder (PTSD) among individuals with severe mental illness (SMI). This is a considerable issue because trauma, posttraumatic stress disorder (PTSD), and severe psychiatric comorbidity are particularly common among Veterans and this symptom presentation clearly exacerbates the overall course and severity of mental illness. This study is significant in that it proposes to establish the efficacy of a frontline exposure based intervention for posttraumatic stress disorder (PTSD), Prolonged Exposure, for improving critical clinical, quality of life, and cost outcomes among Veterans with severe mental illness (SMI) enrolled in VA healthcare. Collectively, it is anticipated that these data will establish a much needed clinical course of action for what is considered a vulnerable yet highly underserved patient population.

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of Posttraumatic Stress Disorder (PTSD) on the Clinician Administered PTSD Scale (CAPS; Blake et al., 1990);
  • A confirmed diagnosis of a psychotic disorder, bipolar disorder, or severe unipolar depression on the Mini Neuropsychiatric Interview (MINI; Sheehan et al., 1998).

Exclusion Criteria

  • Having a household member who is already enrolled in the study;
  • Active psychosis, mania, or dementia at screening;
  • Suicidal ideation with clear intent;
  • Current substance dependence; and
  • Concurrent enrollment in another clinical trial for PTSD or depression.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01542229). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search